8th May 2014 07:30
8 May 2014
Directors' Dealings
Sinclair IS Pharma plc (SPH.L), ("Sinclair" or the "Group") the international specialty pharma company, was informed on 7 May 2014 that earlier that day Stuart Swanson, a Non-Executive Director, acquired 319,146 ordinary shares in Sinclair at an average price of 30.5p per share. Following this purchase Stuart Swanson has a beneficial interest in 9,200,000 ordinary shares representing 1.85% of the Group's issued ordinary share capital.
For further information, please contact:
Sinclair IS Pharma plc Tel: +44 (0) 20 7467 6920
Chris Spooner
Alan Olby
Robert Taylor
Peel Hunt LLP Tel: +44 (0) 20 7418 8900
James Steel
Clare Terlouw
Related Shares:
Sinclair Pharma